Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines

Immunogenetics

Volumn 49, Issue 4, 1999, Pages 287-294

  Griffioen, Marieke ^a   Ouwerkerk, Ilse J M ^a   Harten, Veronique ^a   Gobin, Sam J P ^a   Van Den Elsen, Peter J ^a   Schrier, Peter I ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HLA B; Interferon stimulated response element; Melanoma; Promoter; Transcription

Indexed keywords

HLA A2 ANTIGEN; HLA B ANTIGEN; HLA B7 ANTIGEN; INTERFERON; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; DNA FLANKING REGION; DNA TRANSFECTION; ENHANCER REGION; GENE INDUCTION; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION;

BINDING SITES; DNA-BINDING PROTEINS; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-A2 ANTIGEN; HLA-B7 ANTIGEN; HUMANS; INTERFERON REGULATORY FACTOR-2; INTERFERONS; MELANOMA; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032984594     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050495     Document Type: Article

References (37)

1. Baldwin AS Jr, Sharp PA (1988) Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc Natl Acad Sci USA 85: 723-727
2. Bernards R (1991) N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma. EMBO J 10: 1119-1125
3. Blanchet O, Bourge JF, Zinszner H, Israel A, Kourilsky P, Dausset J, Degos L, Paul P (1992) Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression. Proc Natl Acad Sci USA 89: 3488-3492
4. Bovolenta C, Driggers PH, Marks MS, Medin JA, Politis AD, Vogel SN, Levy DE, Sakaguchi K, Appella E, Coligan JE (1994) Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci USA 91: 5046-5050
5. Burke PA, Hirschfeld S, Shirayoshi Y, Kasik JW, Hamada K, Appella E, Ozato K (1989) Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. J Exp Med 169: 1309-1321
6. Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, Meijer CJ, Walboomers JM (1994) Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 179: 335-340
7. Dey A, Thornton AM, Lonergan M, Weissman SM, Chamberlain JW, Ozato K (1992) Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol Cell Biol 12: 3590-3599
8. Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U, Ozato K (1995) NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J Interferon Cytokine Res 15: 1037-1045
9. Driggers PH, Ennist DL, Gleason SL, Mak WH, Marks MS, Levi BZ, Flanagan JR, Appella E, Ozato K (1990) An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA 87: 3743-3747
10. Girdlestone J (1995) Regulation of HLA class I loci by interferons. Immunobiology 193: 229-237
11. Girdlestone J (1996) Transcriptional regulation of MHC class I genes. Eur J Immunogenet 23: 393-413
12. Girdlestone J, Isamat M, Gewert D, Milstein C (1993) Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. Proc Natl Acad Sci USA 90: 11568-11572
13. Gobin SJP, Peijnenburg A, Keijsers V, Van den Elsen PJ (1997) site α is crucial for two routes of IFNγ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6: 601-611
14. Hakem R, Le Bouteiller P, Jezo Bremond A, Harper K, Campese D, Lemonnier FA (1991) Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences. J Immunol 147: 2384-2390
15. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T (1989) Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739
16. Henseling U, Schmidt W, Scholer HR, Gruss P, Hatzopoulos AK (1990) A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes. Mol Cell Biol 10: 4100-4109
17. Johnson DR, Pober JS (1994) HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol Cell Biol 14: 1322-1332
18. Kushida MM, Dey A, Zhang XL, Campbell J, Heeney M, Carlyle J, Ganguly S, Ozato K, Vasavada H, Chamberlain JW (1997) A 150-base pair 5' region of the MHC class I HLA-B7 gene is sufficient to direct tissue-specific expression and locus control region activity. J Immunol 159: 4913-4929
19. Kushner DB, Pereira DS, Liu X, Graham FL, Ricciardi RP (1996) The first exon of Ad12 E1A excluding the transactivation domain mediates differential binding of COUP-TF and NF-kappa B to the MHC class I enhancer in transformed cells. Oncogene 12: 143-151
20. Liu X, Ge R, Ricciardi RP (1996) Evidence for the involvement of a nuclear NF-kappa B inhibitor in global down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells. Mol Cell Biol 16: 398-404
21. Martin BK, Chin KC, Olsen JC, Skinner CA, Dey A, Ozato K, Ting JP (1997) Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6: 591-600
22. Miyazaki J, Appella E, Ozato K (1986) Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells. Proc Natl Acad Sci USA 83: 9537-9541
23. Peltenburg LT, Dee R, Schrier PI (1993) Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A. Nucleic Acids Res 21: 1179-1185
24. Plaksin D, Baeuerle PA, Eisenbach L (1993) KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells. J Exp Med 177: 1651-1662
25. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mule JJ, Rosenberg SA, Bennink JR (1993) Identification of human cancers deficient in antigen processing. J Exp Med 177:265-272
26. Restifo NP, Marincola FM, Kawakami Y, Taubenberger J, Yannelli JR, Rosenberg SA (1996) Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J Natl Cancer Inst 88: 100-108
27. Schmitz ML, Baeuerle PA (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J 10: 3805-3817
28. Schoneich J, Lee JL, Mansky P, Sheffery M, Yang SY (1997) The pentanucleotide ATTGG, the "Inverted CCAAT", is an essential element for HLA class I gene transcription. J Immunol 158: 4788-4796
29. Schouten GJ, van der Eb AJ, Zantema A (1995) Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A. EMBO J 14: 1498-1507
30. Schrier PI, Peltenburg LT (1993) Relationship between myc oncogene activation and MHC class I expression. Adv Cancer Res 60: 181-246
31. Soong TW, Hui KM (1992) Locus-specific transcriptional control of HLA genes. J Immunol 149: 2008-2020
32. van der Eb AJ, Graham FL (1980) Assay of transforming activity of tumor virus DNA. Methods Enzymol 65: 826-839
33. van't Veer LJ, Beijersbergen RL, Bernards R (1993) N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa. EMBO J 12: 195-200
34. Versteeg R, Noordermeer IA, Kruse-Wolters M, Ruiter DJ, Schrier PI (1988) C-myc down-regulates class I HLA expression in human melanomas. EMBO J 7: 1023-1029
35. Versteeg R, Kruse-Wolters KM, Plomp AC, van Leeuwen A, Stam NJ, Ploegh HL, Ruiter DJ, Schrier PI (1989) Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J Exp Med 170: 621-635
36. Waring JF, Radford JE, Burns LJ, Ginder GD (1995) The human leukocyte antigen A2 interferon-stimulated response element consensus sequence binds a nuclear factor required for constitutive expression. J Biol Chem 270: 12276-12285
37. Yano O, Kanellopoulos J, Kieran M, Le Bail O, Israel A, Kourilsky P (1987) Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers. EMBO J 6: 3317-3324